Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2545-2555

  Liu, Chunnan ^a   Sista, Nirupama D ^a   Pagano, Joseph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSACTIVATION;

EID: 0029993526     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2545-2555.1996     Document Type: Article

References (95)

1. Albrecht, T., M. Nachtigal, J. S. St. Jeor, and F. Rapp. 1976. Induction of cellular DNA synthesis and increased mitotic activity in Syrian hamster embryo cells, abortively infected with human cytomegalovirus. J. Gen. Virol. 30:167-177
2. Anders, D. G., and W. Gibson. 1988. Location, transcript analysis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similarities to ICP8 of herpes simplex virus type I. J. Virol. 62:1364-1372.
3. Aver, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimer partner for Max that antagonizes Myc transcriptional activity Cell 72:211-222.
4. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317-4324.
5. Beckman, H., L. K. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer mE3 motif. Genes Dev. 4:167-169.
6. Beijerbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p 107 in vivo. Genes Dev. 8:2680-2690.
7. Blackwell, T. K., L. Kretsner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
8. Blake, M. C., and J. C. Azizkhan. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol 9:4994-5002.
9. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (London) 355:176-179.
10. Carr, C. S., and P. A. Sharp. 1990. A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol Cell. Biol. 10:4384-4388.
11. Chavrier, P., H. Gruffat, A. Chevallier-Greco, M. Buisson, and A. Sergeant. 1989. The Epstein-Barr virus (EBV) early promoter DR contains cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. J. Virol. 63:607-614.
12. Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and the human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
13. Cheung, A. K. 1989. DNA nucleotide sequence analysis of the immediateearly gene of pseudorabies virus. Nucleic Acids Res. 17:4637-4646.
14. Chevallier-Greco, A., E. Gruffat, A. Manet, A. Calender, and A. Sergeant. 1989. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol. 63:615-623
15. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV) transactivators, EB1 and EB2. are required to activate transcription from an early promoter. EMBO J. 5:3243-3249,
16. Cobrink, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding domain. Genes Dev. 7:2392-2404.
17. Cox, M. A., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators J. Virol. 64:313-321
18. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J 11:1797-1804.
19. Datta, A. K., R. J. Feighny, and J. S. Pagano. 1980 Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoyl-phorbol-13-acetate J. Biol. Chem. 255:5120-5125.
20. Decaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene Cell 54:275-283.
21. DeMarchi, J. M. 1983. Correlation between stimulation of host cell DNA synthesis by human cytomegalovirus and lack of expression of a subset of early virus genes. Virology 129:274-286.
22. Du, H., A. L. Roy, and R. G. Roeder. 1993 Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J 12:501-511.
23. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243:934-937.
24. Feighny, R. J., B. E. Henry H, A. K. Datta, and J. S. Pagano. 1980. Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus Virology 107:415-423.
25. Felser, J. M., P. R. Kinchington, G. Inchauspe, S. E. Straus, and J. M. Ostrove. 1988. Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type I. J. Virol. 62:2076-2082.
26. Fixman, E. D., G. S. Hayward, and S. D. Hayward. 1992. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66:5030-5039.
27. Flemington, E., and S. H. Speck. 1990. Autoregulation of Epstein-Barr virus BZLF1 putative lytic switch gene BZLF1. J. Virol 64:1227-1232.
28. Furnari, F. B., M. D. Adams, and J. S. Pagano. 1992. Regulation of the Epstein-Barr virus DNA polymerase gene. J. Virol. 66:2837-2845.
29. Furnari, F. B., V. Zacny, E. B. Quinlivan. S. Kenney, and J. S. Pagano. 1994 RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J. Virol 68:1827-1836.
30. Ginsberg, R., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
31. Giot, J. F., I. Mikaelian, M. Buisson, E. Manet, I. Joab, J.-C. Nicolas, and A. Sergeant. 1991. Transcriptional interference between the EBV transcription factor EB1 and R: both DNA binding and activation domains of EB1 are required Nucleic Acids Res. 19:1251-1258.
32. Girling, R., J. F. Partridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1994. A new component of the transcription factor DRTF1/E2F Nature (London) 362:83-87.
33. Gorbalenya, A. E., E. B. Koonin, Z. P. Donchenko, and V. M. Blinov. 1988. A conserved NTP motif in putative helicases. Nature (London) 333:22.
34. Gruffat, H., N. Duran, M. Buisson, F. Wild, R. Buckland, and A. Sergeant. 1990 The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res 18:6835-6843
35. Gruffat, H., N. Duran, M. Buisson, F. Wild, R. Buckland, and A. Sergeant. 1992. Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. J. Virol. 66:46-52.
36. Gruffat, H., and A. Sergeant. 1994. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R Nucleic Acids Res. 22:1172-1178.
37. Gutsch, D., K. B. Marcu, and S. C. Kenney. 1994. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters. Cell. Mol. Biol. 40:747-760.
38. Hagemeier, C., R. Caswell, G. Hayhurst, J. Sinclair, and T. Kouzarides. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:2897-2903
39. Hamper, B., A. Tanaka, M. Nonoyama, and J. G. Derge. 1974. Regulation of the resident repressed Epstein-Barr virus genome during the early S-phase (S-1 period) of noninducer Raji cells. Proc. Natl. Acad. Sci. USA 71:631-635.
40. Hardwick, J. M., P. M. Lieberman, and S. D. Hayward. 1988. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:2274-2284.
41. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-bmding protein with properties of the transcription factor E2F. Cell 70:337-350.
42. Helin, K., C. Wu, A. Fattaey, J. Lees, B. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transcription Genes Dev. 7:1850-1861.
43. Hodgman, T. 1988. A new superfamily of replicative proteins. Nature (London) 333:22-23.
44. Holley-Guthrie, E. A., E. B. Quinlivan, E. C. Mar, and S. Kenney. 1990. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J. Virol. 64:3753-3759.
45. Ivey-Hoyle, M., R. Conroy, H. Huber, P. Goodhart, A. Oliff, and D. C. Heinbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol 13:7802-7812.
46. Kaelin, W. G. J., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
47. Kallin, B., L. Sternas, A. K. Saemundssen, J. Luka, H. Jornvall, B. Eriksson, P.-Z. Tao, M. T. Nilsson, and G. Klein. 1985. Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells. J. Virol. 54:561-568.
48. Kenney, S., E. Holley-Guthrie, E.-C. Mar, and M. Smith. 1989. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63:3878-3883.
49. Kenney, S., J. Kamine, E. Holley-Guthrie, J. C. Lin, E. C. Mar, and J. S. Pagano. 1989. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63:1729-1736.
50. Kenney, S. C., E. Holley-Guthrie, E. B. Quinlivan, D. Gutsch, Q. Zhang, T. Bender, J.-F. Giot, and A. Sergeant. 1992. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol. Cell. Biol. 12:136-146.
51. Kovesdi, I., R. Reichel, and J. R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A transactivation. Cell 45:219-228.
52. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560.
53. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
54. Lane, D. 1988. Enlarged family of putative helicases. Nature (London) 334:478.
55. Lear, A. L., M. Rowe, M. G. Kurilla, S. Lee, S. Henderson, E. Kieff, and A. B. Rickinson. 1992. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle J. Virol. 66:7461-7468
56. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors Mol. Cell Biol. 13:7813-7825.
57. Lieberman, P. M., and A. J. Berk. 1991. The Zta-trans-activator protein stabilizes TFHD association with promoter DNA by direct protein-protein interaction. Genes Dev. 5:2441-2454.
58. Liu, F., and M. R. Green. 1994 Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature (London) 368:520-525.
59. Luka, J., B. Kallin, and G. Klein. 1979. Induction of Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate Virology 94:228-231.
60. Manet. E., H. Gruffat, M. C. Trescol-Biemont, N. Moreno, P. Chambard, J. F. Giot, and A. Sergeant. 1989 Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional transactivators. EMBO J. 8:1819-1826
61. Manet, E., A. Rigolet, H. Gruffat, J.-F. Giot, and A. Sergeant. 1991. Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization. DNA binding and activation. Nucleic Acids Res. 19:2661-2667.
62. Meier, J. L., X. Luo, M. Sawadogo, and S. E. Straus. 1994. The cellular transcription factor USF cooperates with varicella-zoster immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol Cell. Biol. 14:6896-6906.
63. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
64. 63a.Nonkwelo, C., J. Skinner, A. Bell, A. Rickinson. and J. Sample. 1996. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:623-627.
65. Nutter, L. M., S. P. Grill, J.-S. Li, R.-S. Tan, and Y.-C. Cheng. 1987. Induction of virus enzymes by phorbol esters and n-butyrate in Epstien-Barr virus genome-carrying Raji cells. Cancer Res. 47:4407-4412.
66. Ou, S.-H., L. F. Garcia-Martinez, E. J. Paulssen, and R. B. Gaynor. 1994. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J Virol. 68:7188-7199.
67. Peritz, L. N., E. J. B. Fodor, D. W. Silversides, P. A. Cattini, J. D. Baxter, and N. L. Eberhardt. 1988. The human growth hormone gene contains both positive and negative control elements. J. Biol Chem. 263:5005-5007.
68. Prendergrast, G. C., and E. B. Ziff. 1991. Methylation-sensitive ssquence-specific DNA binding by the c-Myc basic region. Science 251:186-189.
69. Quinlivan, E., E. Holley-Guthrie, M. Norris, D. Gutsch, S. Bachenheimer, and S. Kenney. 1993. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus promoter, BMRF1. Nucleic Acids Res 21:1999-2007.
70. Quinlivan, E. B., E. Holley-Guthrie, E. C. Mar, M. S. Smith, and S. Kenney. 1990. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent. J. Virol. 64:1817-1820.
71. Reisman, D., and V. Rotter. 1993. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene Nucleic Acids Res. 21:345-350.
72. Rooney, C. M., D. T. Rowe, T. Ragot, and P. J. Farrell. 1989. The spliced BZLF1 gene of Epstein-Barr virus transactivates an early promoter and induces the virus lytic cycle. J. Virol. 63:3109-3116.
73. Roy, A. L., M. Meisterernst, P. Pognonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription factor and the helix-loop-helix activator USF. Nature (London) 354:245-248.
74. Ryon, J. J., E. D. Fixman, C. Houchens, J. Zong, P. M. Lieberman, Y.-N. Chang, G. S. Hayward, and S. D. Hayward. 1993. The lytic origin of herpes-virus papio is highly homologous to Epstein-Barr virus on-Lyt evolutionary conservation of transcriptional activation and replication signals J. Virol. 67:4006-4016.
75. Sample, J., L. Brooks, C. Sample, L. Young, M. Rowe, C. Gregory, A. Rickinson, and E. Kieff. 1991 Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl. Acad Sci. USA 88:6343-6347.
76. Sawadogo, M. 1988. Multiple forms of the human gene-specific transcription factor USF. II DNA binding properties and transcriptional activity of the purified HeLa USF. J. Biol. Chem. 263:11994-12001.
77. Sawadogo, M., and R. G. Roeder. 1985 Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43:165-175
78. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995 The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
79. 77a.Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl. Acad. Sci. USA 92:10565-10569.
80. Schaefer, B. C., M. Woissetsclheiger, J. L. Strominger, and S. Speck. 1991. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 88:6550-6554
81. Siebenlist, U., and W. Gilbert. 1980. Contacts between Escherichia coli RNA polymerase and an early promoter of phase T7. Nature (London) 77:122-126.
82. Sinclair, A. J., M. Brimmell, F. Shanahan, and P. J. Farrell. 1991 Pathways of activation of the Epstein-Barr virus productive cycle. J. Virol. 65:2237-2244.
83. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22:427-433.
84. Sirito, M., S. Walker, Q. Lin, M. T. Kozlowski, W. H. Klein, and M. Sawadogo. 1992 Members of the USF family of helix-loop-helix proteins bind DNA as homo- as well as heterodimers. Gene Expr. 2:231-240.
85. Smith, P. R., and B. E. Griffin. 1992. Transcription of the Epstein-Barr virus gene EBNA1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J. Virol. 66:706-714.
86. Sradet, C., M. Vidal, D. Cobrink, Y. Geng, C. Onufryk, A. Chen. and R. A. Weinberg. 1995. E2F-4 and E2F5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
87. St. Jeor, S. C., T. B. Albrecht, F. D. Funk, and F. Rapp. 1974. Stimulation of cellular DNA synthesis by human cytomegalovirus. J. Virol 13:353-362.
88. Sung, N. S., J. Wilson, M. Davenport, N. D. Sista, and J. S. Pagano. 1994. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell Biol. 14:7144-7152
89. Szekely, L., G. Selivanova, K. P. Magnusson, G. Klein, and K. G. Wiman. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90:5455-5459.
90. Wade, M., M. C. Blake, R. C. Jambou, K. Helin, E. Harlow, and J. C. Azizkhan. 1995. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene. J. Biol. Chem. 270:9783-9791.
91. Wang, Y., and J. D. Hall. 1990. Characterization of a major DNA-binding domain in the herpes simplex type 1 DNA-binding protein (ICP8). J. Virol. 64:2082-2089
92. Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988 Association between an oncogene and an antioncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124-129.
93. Wu, C.-L., and K. W. Wilcox. 1991. The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters. J. Virol. 65:1149-1159.
94. Wu, C. L., L. R. Zukerberg, C. D. Ngwu, E. Harlow, and J. A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol Cell. Biol. 15:2536-2546.
95. Zalani, S., E. Holley-Guthrie, D. Gutsch, and S. Kenney. 1992. The Epstein-Barr virus immediate-early promoter. BRLF1. can be activated by the cellular SP1 transcription factor. J. Virol. 65:3647-3655.